¥3,515.00
0.57%
Tokyo, Oct 05, 02:48 pm JST. Closed.
ISIN
JP3623150004
Symbol
4553

Towa Pharmaceutical Co Stock price

¥3,500.00
-80.00 2.23% 1M
-700.00 16.67% 6M
-140.00 3.85% YTD
+533.00 17.96% 1Y
+783.00 28.82% 3Y
+315.00 9.89% 5Y
+2,116.28 152.94% 10Y
+2,500.92 250.32% 20Y
Tokyo, Closing price Mon, Oct 05 2026
+5.00 0.14%
ISIN
JP3623150004
Symbol
4553
Industry

Is Towa Pharmaceutical Co a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,120 stocks worldwide.

Key metrics

Basic
Market capitalization
¥175.7b
Enterprise Value
¥363.4b
Net debt
¥187.7b
Cash
¥42.2b
Shares outstanding
49.2m
Valuation
P/E
20.8
P/S | estimate
0.6 | 0.6
EV/Sales | estimate
1.3 | 1.2
EV/FCF | ex SBC
153.9 | -
P/B
1.0
Dividends
DPS
¥85.00
Yield 1Y | 5Y
2.4% | 2.5%
Growth 1Y | 5Y
6.3% | 8.3%
Payout 1Y | 3Y
75.0% | 25.6%
Increased
3 Years
Financials
Revenue | estimate
¥279.9b | ¥309.7b
EBITDA
¥47.1b
EBIT
¥24.4b
Net Income
¥8.3b
Free Cash Flow | ex SBC
¥2.4b | -
Growth
Revenue | estimate
6.8% | 13.1%
EBITDA
8.5%
EBIT
7.2%
Net Income
-48.3%
Free Cash Flow
142.0%
Margin
Gross
36.3%
EBITDA
16.8%
EBIT
8.7%
Net
3.0%
Free Cash Flow | ex SBC
0.8% | -
Financial Health
Equity Ratio
37.5%
Return on Equity
3.0%
ROCE
6.4%
ROIC
3.2%
Debt/Equity
1.3
More
EPS
¥168.0
FCF per Share
¥48.0
Short interest
-
Employees
5k
Rev per Employee
¥57.2m

Towa Pharmaceutical Co Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a Towa Pharmaceutical Co forecast:

8x Buy
80%
2x Hold
20%

Analyst Opinions

10 Analysts have issued a Towa Pharmaceutical Co forecast:

Buy
80%
Hold
20%

Financial data from Towa Pharmaceutical Co

Jun '26
+/-
%
279,941 279,941
7% 7%
100%
- Direct Costs 178,413 178,413
7% 7%
64%
101,528 101,528
7% 7%
36%
- Selling and Administrative Expenses 77,112 77,112
7% 7%
28%
- Research and Development Expense - -
-
-
47,065 47,065
8% 8%
17%
- Depreciation and Amortization 22,650 22,650
10% 10%
8%
EBIT (Operating Income) EBIT 24,415 24,415
7% 7%
9%
Net Profit 8,268 8,268
48% 48%
3%

In millions JPY.

Don't miss a Thing! We will send you all news about Towa Pharmaceutical Co directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Towa Pharmaceutical Co., Ltd. engages in the manufacture and distribution of pharmaceutical products. The company is headquartered in Kadoma-Shi, Osaka-Fu and currently employs 4,788 full-time employees. The company went IPO on 2004-04-05. The main products are generic drugs, which are launched after the efficacy and safety of new drugs have been confirmed for a certain period of time. The company is a drug with the same effect, usage and dosage. The firm is involved in the sale and outsourced manufacture of products and generic drugs. The firm is involved in the research and outsourced manufacture of active pharmaceutical ingredient and soft capsules. The firm is also involved in the planning, development, contract manufacturing of health foods, general foods, miscellaneous goods and others.

Head office Japan
Employees 4,788
Website www.towayakuhin.co.jp

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today